BOSTON (MarketWatch) -- Merck KGaA has agreed to buy Millipore Corp., maker of biomedical research products, for approximately $7.2 billion including assumed debt, in a move designed to further build ...
Merck to acquire all outstanding Millipore shares for US$ 107 per share in cash, creating a world-class partner for the life science sector Agreed transaction valued at approximately € 5.3 billion ...
Merck KGaA (Darmstadt, Germany), a global pharmaceutical and chemical company, completed its acquisition of Millipore (Billerica, MA), a life-science company, last Thursday for an aggregate purchase ...
BILLERICA, Mass. & DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA*, a global pharmaceutical and chemical company, today announced the successful completion of its acquisition of Millipore Corporation ...
FRANKFURT, March 1 (Reuters) - Merck KGaA's agreed $6 billion cash purchase of U.S. biotech tool maker Millipore buoyed the German drugmaker's share on Monday as it diversified away from its embattled ...
Merck to acquire Sigma-Aldrich for $140 per share in cash, valuing company at approx. $17 billion (€13.1 billion) Acquisition expands Merck Millipore’s global reach, increasing the company’s presence ...
On Nov. 18, Merck KGaA closed on the biggest acquisition in its 347-year history: The $17.0 billion purchase of the research-chemical supply house Sigma-Aldrich. Announced in September 2014, the deal ...
In early September, Merck KGaA’s MilliporeSigma unit made a $65 million splash to boost production of ingredients for next-generation oncology meds in Wisconsin—but that was only a piece of the life ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback